b Tested in sodium chloride 0.9%.
c Tested in sodium chloride 0.45%.
d Test performed using the formulation WITHOUT edetate disodium.
e Tested in Ringer’s injection, lactated.
f Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.
g Imipenem component. Imipenem in a 1:1 fixed-ratio concentration with cilastatin.
h Tested in both dextrose 5% and sodium chloride 0.9%.
i Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
j Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.
k Ceftazidime component. Ceftazidime in a 4:1 fixed-ratio concentration with avibactam.
l Tested in dextrose 5%, sodium chloride 0.9%, and Ringer’s injection, lactated.
m Imipenem component. Imipenem in a 2:2:1 fixed-ratio concentration with cilastatin and relebactam.
o Bitartrate salt of epinephrine tested.
p Tested with epinephrine bitartrate (MPI) 60 mcg/mL
q Tested with sildenafil (PF) 0.8 mg/mL.
r Tested with norepinephrine bitartrate (HOS) 60 mcg/mL
s Tested with milrinone lactate (SAN) 0.2 mg/mL.
t Tested as the premixed infusion solution.
v Tested with epinephrine (PAR) 16 mcg/mL in dextrose 5%.
w Tested with epinephrine (PAR) 64 mcg/mL in dextrose 5%.
x Tested with calcium chloride (IMS) 100 mg/mL.
y Tested with calcium chloride (IMS) 20 mg/mL in dextrose 5%.
z Tested with heparin sodium (HOS) 2 units/mL premixed infusion solution in sodium chloride 0.9%.
aa Tested with heparin sodium (HOS) 100 units/mL premixed infusion solution in sodium chloride 0.45%.
bb Tested with milrinone lactate (HIK) 200 mcg/mL in dextrose 5%.
cc Tested with milrinone lactate (HIK) 400 mcg/mL in dextrose 5%.
ff Subvisible particulate test methods include light obscuration, flow imaging microscopy, and backgrounded membrane imaging.
gg Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.